| Date Filed | Type | Description |
| 10/03/2023 |
4
| Anderson Raymond (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 2,533 restricted stock units
@ $0 |
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Anderson Raymond (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 2,533 restricted stock units
@ $0 |
|
| 02/03/2023 |
4
| Anderson Raymond (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Granted 13,930 options
@ $3.16, valued at
$44k
Granted 10,133 restricted stock units
@ $0 |
|
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Anderson Raymond (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 2,859 restricted stock units
@ $0 |
|
| 02/04/2022 |
4
| Anderson Raymond (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Granted 15,128 options
@ $2.8, valued at
$42.4k
Granted 11,436 restricted stock units
@ $0 |
|
| 01/04/2022 |
4
| Anderson Raymond (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 751 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Anderson Raymond (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 751 restricted stock units
@ $0 |
|
| 01/28/2021 |
4
| Anderson Raymond (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Granted 4,443 options
@ $6.81, valued at
$30.3k
Granted 3,005 restricted stock units
@ $0 |
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2020 |
4
| Anderson Raymond (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 322 restricted stock units
@ $0 |
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/26/2016 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Unknown transaction of 6,695 shares
@ $9, valued at
$60.3k
Disposed/sold 8,330 shares
@ $9, valued at
$75k
Disposed/sold 30,000 options to buy
@ $2.97, valued at
$89.1k
Disposed/sold 90,000 options to buy
@ $3.54, valued at
$318.6k
Disposed/sold 120,000 options to buy
@ $5.13, valued at
$615.6k
Disposed/sold 50,000 options to buy
@ $5.49, valued at
$274.5k
|
|
| 06/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/04/2015 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 4,916 shares
@ $12.508, valued at
$61.5k
Exercised 4,916 options to buy
@ $2.02, valued at
$9.9k
|
|
| 09/02/2015 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 8,084 shares
@ $12.5176, valued at
$101.2k
Exercised 8,084 options to buy
@ $2.02, valued at
$16.3k
|
|
| 05/21/2015 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 5,021 shares
@ $0
Granted 18,996 options to buy
@ $11.55, valued at
$219.4k
|
|
| 03/26/2015 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 21,619 shares
@ $12, valued at
$259.4k
Exercised 11,313 options to buy
@ $2.57, valued at
$29.1k
Exercised 8,306 options to buy
@ $2.57, valued at
$21.3k
Exercised 2,000 options to buy
@ $2.02, valued at
$4k
|
|
| 02/11/2015 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 1,674 shares
@ $0
Granted 6,332 options to buy
@ $9.36, valued at
$59.3k
|
|
| 01/14/2015 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 10,000 shares
@ $10.575, valued at
$105.8k
Exercised 10,000 options to buy
@ $2.57, valued at
$25.7k
|
|
| 09/12/2014 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 10,000 shares
@ $10.8074, valued at
$108.1k
Exercised 10,000 options to buy
@ $2.57, valued at
$25.7k
|
|
| 07/09/2014 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 27,500 shares
@ $11.2137, valued at
$308.4k
Exercised 27,500 options to buy
@ $2.57, valued at
$70.7k
|
|
| 03/11/2014 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 12,500 shares
@ $15.7223, valued at
$196.5k
Exercised 12,500 options to buy
@ $2.57, valued at
$32.1k
|
|
| 02/11/2014 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 50,000 options to buy
@ $14.74, valued at
$737k
|
|
| 01/09/2014 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 10,000 shares
@ $13.2532, valued at
$132.5k
Exercised 10,000 options to buy
@ $2.57, valued at
$25.7k
|
|
| 11/12/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|